Skip to main content
Clinical Trials/NCT05752266
NCT05752266CompletedNot Applicable

Effect of Probiotics on Amino Acid Absorption

Singapore Institute of Technology1 site in 1 country20 target enrollmentStarted: March 27, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Change in gut microbiota population size

Study Overview

Brief Summary

The goal of this clinical trial is to test effects of consuming probiotics in healthy adults. The main question it aims to answer is:

• Do consuming probiotics affect a healthy adult's ability to absorb amino acids from plant proteins?

Participants will

  • Consume one dose of probiotic pills per day after meals for two weeks
  • Consume one dose of plant-based plant protein beverage after an overnight fast and collection of one 5 ml fasting blood sample
  • Undergo blood draw of 6 more 5 ml blood samples for the next 3 hours after consuming plant-based protein beverage

Detailed Description

There is increasing evidence that the gut microbiota contributes to a range of immune, inflammatory, and metabolic responses. Numerous studies have shown that administrating probiotics - strains of bacteria that benefits intestinal function - confer benefits to the host's immune system. Except for soy protein, plant proteins are incomplete proteins lacking in one or more essential amino acids. The incomplete amino acid profile of most plant proteins is compounded by their lower rate of absorption as compared to animal protein. Hence, the investigators aim to investigate the administration of probiotics as a potential strategy to overcome compositional shortcomings of plant proteins by improving the gastrointestinal absorption of plant-based proteins.

The aim of Stage 1 is to formulate a plant-based protein beverage with optimized amino acid profile with consumer acceptance.

Stage 2 of this study will be to conduct a randomized, double-blind, placebo-controlled, crossover trial using the formulation developed in Stage 1, together with probiotics supplementation to evaluate the effect of probiotics on the absorption of amino acids from plant proteins.

The probiotics to be studied will be provided by the Asian Microbiome Library (AMILI) with the plant protein beverage to be developed within SIT. Findings from this mutually beneficial collaborative project with AMILI will pave the way to further understand the role of probiotics in human health, particularly its effect in nutrient absorption of plant protein.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Care Provider)

Masking Description

Masked personnel will be unaware of which arm each participant is allocated to, and what type of probiotics have been assigned to each participant.

Eligibility Criteria

Ages
21 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Be willing and able to comply with study procedures and give written informed consent
  • •Self-reported to be healthy
  • •Within healthy BMI weight range (18.5-23kg/m2)

Exclusion Criteria

  • •Any chronic medical condition
  • •Individuals who were treated for or diagnosed with a gastrointestinal, cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, haematological, neurological or endocrinological disorder
  • •Antibiotic use
  • •Prebiotics, probiotics, synbiotics, and/or digestive enzymes use
  • •Food allergy/intolerances/avoidances towards eggs, soya, peanuts, tree nuts, crustaceans, and gluten
  • •Alcohol consumption

Arms & Interventions

Probiotic Arm

Experimental

Participants allocated to PRO arm will be administered personalized probiotic pills.

Intervention: AMILI Probiotic pills (Dietary Supplement)

Placebo Arm

Placebo Comparator

Participants allocated to PRO arm will be administered maltodextrin placebo pills similar in appearance to probiotic pills.

Intervention: Placebo pills (Dietary Supplement)

Outcomes

Primary Outcomes

Change in gut microbiota population size

Time Frame: 0 to 6 weeks after start of study

Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study). These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.

Change in blood amino acid concentration

Time Frame: 0 to 150 minutes after ingestion of plant protein beverage on each study visit

Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. These blood samples will be analyzed for amino acid profile using mass spectrometry methods.

Change in gut microbiota type

Time Frame: 0 to 6 weeks after start of study

Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study). These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.

Secondary Outcomes

  • Change in blood glucose level(0 to 150 minutes after ingestion of plant protein beverage)
  • Change in blood insulin level(0 to 150 minutes after ingestion of plant protein beverage)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Verena Tan Ming Hui

Associate Professor

Singapore Institute of Technology

Study Sites (1)

Loading locations...

Similar Trials